FDA inspection
Ari-Med Pharmaceuticals: FDA inspection ending Nov 15, 2018
FDA inspection 1075268 · No Action Indicated (NAI) · Tempe, AZ
Key facts
| Inspection ID | 1075268 |
|---|---|
| Firm | Ari-Med Pharmaceuticals |
| FEI number | 2027206 |
| Address | 1615 W University Dr Ste 135 |
| City | Tempe |
| State | AZ |
| ZIP | 85281 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Nov 15, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data